BN Agrochem (526125)

Score breakdown: P/E: 0/3 · ROCE: 2/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

Reading the tape on BN Agrochem makes me uncomfortable. A trading and distribution company with a ₹179 Cr market cap, a P/E of 49.5, and a P/B of 24.8 against a book value of just ₹6.85 is not a bargain by any Graham measure. The 125.44% sales growth sounds exciting, but the latest quarter shows ₹192 Cr of revenue and a net loss of ₹7 Cr. Growth that loses money is not growth; it is consumption of shareholder capital. Profit growth is -167.20%, ROE is -46.67%, and the Piotroski score is only 4/9. Those are the fingerprints of financial stress, not quality. The 27.44% ROCE may look attractive, but when the equity base is only ₹6.85 per share, a small operating profit can generate a big ROCE while shareholders still lose money after interest. The current price of ₹170 is even below the quoted 52-week low of ₹195, which tells me this is falling knife territory. Dividend yield is zero, promoter holding is unavailable, and the PEG ratio of 0.39 is meaningless when current earnings are negative. In a trading and distribution business, there is no durable moat—you are a middleman fighting for margins. I would not confuse a busy top line with a good business. Without debt details, promoter conviction, or a clear path to positive net profit, this remains a speculative operation. It might become a turnaround if management can convert these enormous sales into margins, but I need evidence, not hope. As Buffett says: 'The first rule is not to lose money.' This stock fails that test as a value investment today.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer